Trends of Breast Cancer and its Management in the Last Twenty Years in Aden and Adjacent Governorates, Yemen

  • Harhra, Nasser Aa (Department of Surgery, University of Aden) ;
  • Basaleem, Huda O. (Department of Community Medicine and Aden Cancer Center Faculty of Medicine, University of Aden)
  • Published : 2012.09.30


Background: Breast cancer is the most common cancer of women and the principal cause of death in middle aged women. The objective of this study was to describe the trend of breast cancer and its management in Aden and adjacent south-eastern governorates of Yemen during the last 20 years. Patients and Methods: This is a retrospective analysis of previous studies on patients with breast cancer in Aden and adjacent south-eastern governorates, Yemen (January 1989 through December 2007). The studied variables were: sex, age, time and type of presentation, disease stage, pathological types and the performed surgical treatment. The sources of information were the treatment registry of Aden health office, archives of Al-Gamhouria teaching hospital; major referral and other public and private hospitals in Aden and Aden Cancer Registry. Results: The total number of patients was 476, 99% being females. The age range was 19-88 years. The most affected age was 30-50 years (60.5%), 95% presenting after one month of having breast symptoms. Forty-five percent presented with signs of advanced local disease, while 59.2% had palpable axillary lymph nodes on presentation. Early breast cancer (stages I-II) occurred in 47%, and late breast cancer (stages III-IV) in 51.5%. Invasive ductal carcinoma was the commonest pathology (89.3%). The main surgical treatment was mastectomy (modified radical mastectomy (50%). Conclusion: Breast cancer is predominantly a disease of young with late presentation and advanced disease. Improving health awareness and earlier diagnosis of the disease by health education, encouraging breast self-examination, and providing the mammography equipment and mammary clinics in hospitals are recommended. Establishment of oncology and radiotherapy centers in Aden is a necessity.


  1. Abdul Hamid G, Tayyeb MS, Bawazir AA (2004). Breast Cancer in South-East Republic of Yemen. Yemen Health Med ResJ, 4, 39-43.
  2. Aghassi I M , Green M , Shohat S (2002). Familial Risk Factors For breast cancer among Arab women. Eur J Cancer Prev, 11, 327-31.
  3. Al-Hadrani A, Al-Aulagi S, Qubaty M (2000). Breast Cancer in Yemeni Women . J Nat AppSc, 4, 185-7.
  4. Al-Thobhani AK, Raja'a YA, Noman TA (2001). The pattern and distribution of malignant neoplasms among Yemeni patients. Saudi Med J, 22, 910-3.
  5. Anderson WF, Jatoi I, Devesa SS (2006). Assessing the impact of screening mammography: breast cancer incidence and mortality rates in Connecticut (1943-2002). Breast Cancer Res Treat, 99, 333-40.
  6. BaSaleem HO, Bawazir AA, Moore M, Al-Sakkaf KA (2010). Five Years Cancer Incidence in Aden Cancer Registry, Yemen (2002-2006). Asian Pacifc J Cancer Prev, 11, 507-11
  7. Bawazir AA, Abdul Hamid G, Morales E (1998). Available data on cancer on the South-Eastern governorates of Yemen. Eastern Mediterranean Health J, 4, 101-13.
  8. Bawazir AA, Abdul Hamid G (2002). Pattern of cancer in Aden City 1997- Yemen. Yemeni J Med Health Res, 1, 47-58.
  9. Beral V (2003). Breast cancer and hormone-replacement therapy in the Million Women study. Lancet, 362, 419-27.
  10. Bernier MO, Plu-Bureau G, Bossard N, Ayzac L, Thalabard JC (2000). Breastfeeding and risk of breast cancer: a metaanalysis of published studies. Hum Reprod Update, 6, 374-86.
  11. Bernstein L (2002). Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland BiolNeoplasia, 7, 3-15.
  12. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ (2000). Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-98:comparison of observed with predicted mortality. BMJ, 321, 665-9.
  13. Boyle P, Ferlay J (2005). Cancer incidence and mortality in Europe, 2004. Ann Oncol, 16, 481-8.
  14. Bray F, McCarron P, Parkin DM (2004). The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res, 6, 229-39.
  15. Breen N, Wagener DK, Brown ML, et al (2001). Progress in cancer screening over a decade : results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst, 93, 1704-13.
  16. Buchholz TA, Tucker SL, Erwin J, et al (2001): Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J ClinOncol, 19, 2240-6.
  17. Buzdar AU, Ibrahim NK, Francis D, et al (2005). Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol, 23, 3676-85.
  18. Chen AM, Meric-Bernstam F, Hunt KK, et al (2004). Breast conservation after neoadjuvant chemotherapy : the M. D. Anderson Cancer Center experience. J Clin Oncol, 22, 2303-12.
  19. Chlebowski RT, Chen Z, Anderson GL, et al (2005). Ethnicity and breast cancer : factors influencing differences in incidence and outcome. J Natl Cancer Inst, 97, 439-48.
  20. Clarke M, Collins R, Darby S, et al(2005). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet, 365, 1687-717.
  21. El Saghir N, Ali S, Fady G (2002). Breast cancer in Lebanon. Leb Med J, 50, 3-9.
  22. Elatar L (2002). Cancer Registration, Egypt (2001). Cairo. Egypt. National Cancer Institute .(Available from: www. nci. edu. eg/journal/nci2001%20Pdf )
  23. Ferlay J, Bray F, Pisani P , et al (2004). Cancer Incidence , Mortality and Prevalence Worldwide. GLOBOCAN 2002 . IARC Cancer Base No. 5. Version 2.0. Lyon: IARC Press. (Available at: .
  24. Fisher B, Anderson S, Bryant J (2002). Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 347, 1233-41.
  25. Fisher B, Dignam J, Tan-Chiu E, et al (2001). Prognosis and treatment of patients with breast tumors of 1 cm or less and negative axillary lymph nodes. J Natl Cancer Inst, 93, 112-20.
  26. Fregene A, Newman LA (2005). Breast cancer in Sub-Saharan Africa: how does it relate to breast cancer in African- American women? Cancer, 103, 1540-50.
  27. Gamal MS (2008). Management of patients with breast cancer in Aden public and private hospitals, during the period September 2005 through to June 2007. Thesis for Master degree in general surgery-Faculty of Medicine-Aden University.
  28. Hadi N, Sadeghi A, Talei A, et al (2002). Assessment of Breast Cancer Screening Program in Shiraz , Islamic Republic of Iran. East Mediterranean Health J, 8, 388-91.
  29. Harhra NA (2005). Management of patients with breast cancer at Algamhouria teaching hospital - Aden,Yemen; during two years (December 1998 through December 2002). J Nat App Sc, 14, 34-9.
  30. Hisham AN, Yip CH (2004). Overview of breast cancer in Malaysian women: a problem with late diagnosis. Asian J Surg, 27, 130-3.
  31. Hortobagyi GN, Salazar JG, Pritchard K, etal (2005). The global breast cancer burden: variations in epidemiologyand survival. Clin Breast Cancer, 6, 391-401.
  32. Jamal A A (2001). Pattern of breast diseases in a teaching hospital in Jeddah , Saudi Arabia . Saudi Med J, 22, 110-13.
  33. Jardines L, Haffty BG, Doroshow JH (2003). Stages 0 and I breast cancer. In: Cancer management: A multidisciplinary approach. The Oncology Group , Publishers of Oncology , Oncology News International ; New York : pp189- 203.
  34. Jemal A, Clegg LX, Ward E, et al (2004). Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer, 101, 3-27.
  35. Jemal A, Siegel R, Xu J, et al (2010). Cancer Statistics 2010. Cancer Journal for Clinicians, 60, 277-300.
  36. Kaufmann M, von Minckwitz G, Smith R, et al (2003). International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol, 21, 2600-8.
  37. Kawase K, DiMaio DJ, Tucker SL (2005). Paget,s disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol, 12, 391-7.
  38. Lawrence C, ELHag I, Kollur S (2003). Breast disease in the northern region of Saudi. Saudi Med J, 24, 623-7.
  39. Lacey JV, Devesa S, Brinton LA (2002). Recent Trends in Breast Cancer incidence and mortality. Environ Mol Mutagen, 39, 82-8. (Available from
  40. Lagerlund M , Bellocco R , Karlsson P, et al (2005). Socioeconomic factors and breast cancer survival - a populationbased cohort study (Sweden). Cancer Causes Control, 16, 419-30.
  41. Nyström L, Andersson I, Bjurstam N, et al ( 2002) .Long-term effects of mammography screening. Lancet, 359, 909-19.
  42. Olsson S, Andersson I, Karlberg I, et al (2000) . Implementatioof service screening with mammography in Sweden: from pilot study to nationwide programme . J Med Screen, 7, 14-8.
  43. O'Malley CD, Le GM, Glaser SL, et al (2003).Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study . Cancer, 97, 1303-11.
  44. Parkin DM, Bray F, Ferlay J, et al (2005) . Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
  45. Ries LAG, Eisner MP, Kosary CL, et al (2004). SEER Cancer Statistics Review,1975-2001, Bethesda, MD: National Cancer Institute. ( Available at: csr/1975_2001).
  46. Satae MH (2005). Case-control study of risk factors in Yemeni patients with cancer of breast . Thesis for Master degree in general surgery- Faculty of Medicine-Aden University .
  47. Saunders RS (2008 ). The Breast: Carcinoma of the breast. In: Williams NS, Bulstrode CJK and O, Connell PR, eds. Bailey and Love`s Short Practice of Surgery. 25th edition. UK , London ; Edward Arnold: pp 836-48.
  48. ShenY, Yang Y, Inoue LY, et al (2005). Role of detection method in predicting breast cancer survival: analysis of randomized Screening trials. J Natl Cancer Inst, 97, 1195-203.
  49. Sledge G, Neuberg D, Bernardo P (2003). Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: An intergroup trial (E1193). J Clin Oncol, 21, 588-92.
  50. Smigal C, Jemal A, Ward E, et al (2006). Trends in Breast Cancer by Race and Ethnicity. Update 2006. CA Cancer J Clin, 56, 168-83.
  51. Swan J, Breen N, Coates RJ, et al (2003). Progress in cancer screening practices in the United States. Cancer, 97, 1528-40
  52. United States Breast Cancer Statistics (2012) (Available at http://
  53. Velie EM, Schairer C, Flood A, et al (2005) . Empirically derived dietary patterns and risk of postmenopausal breast cancer in a large prospective cohort study. Am J Clin Nutr, 82, 1308-19.
  54. Veronesi U , Salvadori B , Luini A (1990). Conservation treatment of early breast cancer : long-term results of 1232 cases treated with quadrantectomy , axillary dissection , and radiotherapy. Ann Surg, 211, 250-9.
  55. Vorobiof DA , Sitas F, Vorobiof G (2001) . Breast cancer incidence in South Africa. J Clin Oncol, 19, S125-7.
  56. Walker ARP, Adam FI, Walker BF (2004) . Breast cancer in black African women : a changing situation. J R Soc Health, 124, 81-5
  57. Ward E, Jemal A, Cokkinides V, et al (2004). Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin, 54, 78-93.

Cited by

  1. Curcumin Inhibits TGF-β1-Induced MMP-9 and Invasion through ERK and Smad Signaling in Breast Cancer MDA-MB-231 Cells vol.13, pp.11, 2012,
  2. Overview of Cancer Registration Research in the Asian Pacific from 2008-2013 vol.14, pp.8, 2013,
  3. Assessment of Midwifery Student Preparation for Performing the Role of Breast Cancer Educator vol.15, pp.14, 2014,
  4. Trends in Incidence of Breast Cancer among Women under 40 in Asia vol.15, pp.3, 2014,
  5. Incidence Data for Breast Cancer among Yemeni Female Patients with Palpable Breast Lumps vol.16, pp.1, 2015,